Tharimmune Inc
For the period ended Jun 30, 2024. Filed Aug 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 9, 2024
CNTN$2.06+6.7%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Condensed Consolidated Balance Sheets as of June 30, 2024 (Unaudited) and December 31, 2023
CONDENSED CONSOLIDATED BALANCE SHEETS
| June 30, 2024 | December 31, | |
|---|---|---|
| (Unaudited) | 2023 | |
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $7,895,827 | $10,935,352 |
| Prepaid expenses and other current assets | 301,620 | 11,041 |
| Deferred offering costs | 60,000 | - |
| Total current assets | 8,257,447 | 10,946,393 |
| Total assets | $8,257,447 | $10,946,393 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities | ||
| Accounts payable | $784,029 | $908,577 |
| Accrued expenses | 579,462 | 906,469 |
| Insurance premium financing liability | 200,048 | - |
| Total current liabilities | 1,563,539 | 1,815,046 |
| Total liabilities | 1,563,539 | 1,815,046 |
| Commitments and contingencies (see Note 5) | - | - |
| Stockholders’ equity | ||
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of June 30, 2024 and December 31, 2023 | - | - |
| Common stock, $0.0001 par value, 250,000,000 shares Authorized, 1,095,346 shares and 884,720 shares issued and 1,095,100 shares and 884,474 shares outstanding as of June 30, 2024 and December 31, 2023, respectively* | 111 | 89 |
| Additional paid-in capital | 36,048,454 | 33,904,749 |
| Accumulated deficit | (29,284,692) | (24,703,526) |
| Treasury stock, at cost, 246 shares held in treasury as of June 30, 2024 and December 31, 2023 | (69,965) | (69,965) |
| Total stockholders’ equity | 6,693,908 | 9,131,347 |
| Total liabilities and stockholders’ equity | $8,257,447 | $10,946,393 |
| * | Amounts have been retroactively restated to reflect the 1-for-15 reverse stock split effectuated on May 24, 2024 (See Note 2 to the condensed consolidated financial statements). |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.